期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
对腹主动脉瘤死亡率筛查的影响:人群随机对照试验
1
作者 Norman P.E. Jamrozik K. +1 位作者 Lawrence-Brown M. M. 王亭忠 《世界核心医学期刊文摘(心脏病学分册)》 2005年第4期16-16,共1页
Objective: To assess whether screening for abdominal aortic aneurysms in men r educes mortality. Design: Population based randomised controlled trial of ultras ound screening, with intention to treat analysis of age s... Objective: To assess whether screening for abdominal aortic aneurysms in men r educes mortality. Design: Population based randomised controlled trial of ultras ound screening, with intention to treat analysis of age standardised mortality. Setting: Community based screening programme in Western Australia. Participants: 41 000 men aged 65-83 years randomised to intervention and control groups. Int ervention: Invitation to ultrasound screening. Main outcome measure: Deaths from abdominal aortic aneurysm in the five years after the start of screening. Resul ts: The corrected response to invitation to screening was 70%. The crude preval ence was 7.2%for aortic diameter ≥.30 mm and 0.5%for diameter ≥.55 mm. Twice as many men in the intervention group than in the control group underwent elect ive surgery for abdominal aortic aneurysm(107 v 54, P=0.002, χ2 test). Between scheduled screening and the end of follow up 18 men in the intervention group an d 25 in the control group died from abdominal aortic aneurysm, yielding a mortal ity ratio of 0.61(95%confidence interval 0.33 to 1.11). Any benefit was almost entirely in men aged between 65 and 75 years, where the ratio was reduced to 0.1 9(0.04 to 0.89). Conclusions: At a whole population level screening for abdomina l aortic aneurysms was not effective in men aged 65-83 years and did not reduce overall death rates. The success of screening depends on choice of target age g roup and the exclusion of ineligible men. It is also important to assess the cur rent rate of elective surgery for abdominal aortic aneurysm as in some communiti es this may already approach a level that reduces the potential benefit of popul ation based screening. 展开更多
关键词 腹主动脉瘤 随机对照试验 选择性手术 流行率 干预组 西澳大利亚
下载PDF
外周动脉疾病的药物治疗
2
作者 Graeme J. Hankey Paul E. Norman +2 位作者 John W. Eikelboom 陈夏欢(译) 刘梅林(校) 《美国医学会杂志(中文版)》 2007年第4期226-232,共7页
背景:外周动脉疾病(peripheral arterial disease,PAD)见于大约20%的55岁以上成人,是心肌梗死、卒中和血管性死亡的有力预测因素。其治疗目标是预防主要冠状动脉和脑血管事件,改善下肢症状。 目的:对药物治疗PAD的最佳证据进... 背景:外周动脉疾病(peripheral arterial disease,PAD)见于大约20%的55岁以上成人,是心肌梗死、卒中和血管性死亡的有力预测因素。其治疗目标是预防主要冠状动脉和脑血管事件,改善下肢症状。 目的:对药物治疗PAD的最佳证据进行评估。 证据获取:检索MEDLINE和Cochrone数据库,对1990—2005年11月药物治疗PDA的随机试验进行汇总分析,同时检索这些文章的参考文献。检索词(单独和组合)包括:外周动脉病、外周动脉疾病、PAD、随机对照试验、对照试验、随机和汇总分析(metaanalysis)。特别关注PAD临床相关药物治疗的随机对照试验和汇总分析。预后评价指标包括腿部症状(间歇性跛行和行走距离)、死亡以及主要冠状动脉及脑血管事件。 证据综合:戒烟(医生建议、尼古丁替代治疗和bupropion)、系统锻炼计划、他汀类药物、西洛他唑(cilostazol)和血管紧张素转换酶抑制剂(ACE抑制剂)可改善间歇性跛行症状、行走距离和生活质量。使用ACE抑制剂和其他降压药物控制血压、服用他汀类药物、使用阿斯匹林或氯吡格雷进行抗血小板治疗、可能还有戒烟均可降低发生主要心脑血管事件的危险。 结论:改善生活方式(戒烟、锻炼)和药物治疗(尼古丁替代治疗、bupropion、降压药物、他汀类药物和抗血小板药物)可降低PAD不断增加的沉重负担,减少局部及全身并发症。 展开更多
关键词 外周动脉疾病 药物治疗 血管紧张素转换酶抑制剂 尼古丁替代治疗 随机对照试验 心脑血管事件 bupropion ARTERIAL
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部